Latest Investments News

Finder Energy’s KTJ offshore development in Timor-Leste has achieved a key milestone with an independent classification of 22.2 million barrels of 2P reserves, underpinning its push toward a Final Investment Decision.

Emyria has cleared a key operational hurdle by resolving Authorised Prescriber capacity constraints in Perth and Queensland, enabling a planned expansion of treatment days in Q4 2026 through the recruitment of 15 new therapists.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Eureka Group Holdings (ASX: EGH) posted a 29% rise in underlying EBITDA for FY26, driven by rapid growth in its all-age rental segment and disciplined capital deployment, while statutory profit dipped due to one-off costs and tax adjustments.

Global Lithium Resources has secured critical environmental and water permits for its Manna Lithium Project, clearing the way for early works and construction. These approvals align with the company’s aggressive schedule targeting first ore shipment in mid-2027.

Noumi Limited lifted FY26 revenue by 8.8% and adjusted operating EBITDA by 7.6%, driven by Dairy & Nutritionals' strong earnings and strategic investments in Plant-based Milks. The company faces refinancing uncertainty with $610 million convertible notes maturing in May 2027, prompting a proposed acquisition by majority shareholder Arrovest.

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.

Universal Store Holdings (ASX:UNI) posted a 12.9% revenue increase to $376.1 million in FY26, driven by strong like-for-like sales and store expansion. Underlying EBIT climbed 17.2% despite a $23.8 million impairment on CTC assets, while net profit after tax fell 21.6%. CEO Alice Barbery will retire in October, succeeded by George Do.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

Dexus (ASX: DXS) reported steady FY26 results with AFFO of 45.0 cents per security and distributions of 37.0 cents, while initiating a strategic review of infrastructure funds following an adverse APAC court judgment.

Vicinity Centres lifted its FY26 net profit after tax by 38.5% to $1.39 billion, supported by a 2.9% revenue increase and a 3.9% rise in funds from operations. The retail property trust declared a final unfranked distribution of 6.20 cents per stapled security, continuing its steady payout policy.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.